National Medical Weight Loss Programme – Ozempic

Weight loss injection pen Ozempic, Sunderland, Fulwell

Contact Us For A Consultation

A simple injection is self-administered weekly with an easy-to-use pen that is pre-filled with the medication

£185 per treatment

Book an appointment/consultation

What is Ozempic?

Ozempic is a once-a-week self-administered injection. It contains the active ingredient Semaglutide. It was first licenced as a treatment for people with type 2 diabetes, as it reduces appetite and increases insulin productivity. It is likely that is will soon be used as a treatment for weight loss for those who are overweight or obese, because of its appetite-reducing properties.

Semaglutide, is 94% identical to the naturally occurring hormone (GLP-1) which is produced in the gut after eating. This hormone regulates appetite and insulin secretion. It also slows down the emptying of the stomach so people who take it have a longer sensation of feeling full which, in turn, reduces the amount of food eaten. This is both good for type 2 diabetes and those seeking to lose weight.

All healthcare professionals in England (other than pharmacists) are required to register with the Care Quality Commission (CQC) to offer this service.

Orchid Aesthetics has been inspected and is regulated by the CQC.

Benefits of Ozempic

  • Weight loss as part of a calorie-controlled diet with exercise
  • Effective and relatively few side effects
  • Treatment is administered at home for ease

Treatment information

A simple injection is self-administered weekly with an easy-to-use pen that is pre-filled with the medication.

Each pen lasts 4 weeks.

  • Ozempic® contains an FDA approved medication called Semaglutide
  • Semaglutide is licensed to treat type-2 diabetes under the name of Ozempic® and is currently going through clinical trials to gain a license for the treatment of weight loss
  • In the meantime, Ozempic® can safely and legally be prescribed “off-label” to treat weight loss

Prices

Treatment Price
Per treatment £185